Clinical Trials Browser

Phase 2 × NIH × carotuximab × Clear all

NCT01727089 2018-08-28

Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer

Phase 2 Completed

59 enrolled 12 charts

Carcinoma, Renal Cell

NCT01375569 2017-07-28

TRC105 for Liver Cancer That Has Not Responded to Sorafenib

Phase 2 Completed

11 enrolled 10 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01328574 2017-01-13

TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma

Phase 2 Completed

13 enrolled 15 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms